Search Results - Tubiana-Mathieu, N.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

    Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer by Cinieri, S., Chan, Arlene, Altundag, K., Vandebroek, A., Tubiana-Mathieu, N., Barnadas, A., Dodyk, P., Lazzarelli, S., Botha, M., Rauch, D., Villanova, G., Coskun, U.

    Published 2017
    Get full text
  2. 2
    Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer

    Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer by Chan, Arlene, Conte, P., Petruzelka, L., Tubiana-Mathieu, N., Ganju, V., Llombart, A., Espie, M., Majois, F., Gil, M., Vaissiere, N., Villanova, G.

    Published 2013
    Get full text

Search Tools: